Karen Atkin

Dr. Atkin oversees a broad range of critical functions including Group Strategy and Five-year Planning; Group Human Resources; International Commercial Operations outside of the US and China; Group Business Development & Alliance Management and Global Quality.

Dr. Atkin joined HUTCHMED in 2021. She is a registered physician with advanced level qualifications in Internal Medicine and Pharmaceutical Medicine. After starting her career in the U.K. National Health Service, Karen went on to spend 29 years in the pharmaceutical industry, with 24 years at AstraZeneca in senior Medical, Regulatory, Pharmacovigilance, R&D, and Commercial leadership roles. Her roles at AstraZeneca included Senior Vice President of Medical for BioPharmaceuticals, Vice President of the Global Infection, Neuroscience and Autoimmunity Therapy Area and the Established Brand business; Country President of Indonesia; and importantly leading China R&D for over four years.

Dr. Atkin holds three Bachelor’s degrees in Physiology, Medicine, and Surgery from University College London. She graduated with a First Class Honours degree in Medicine, holds an MBA from the Open University, is a Member of the Royal College of Physicians, and is a Fellow of the Faculty of Pharmaceutical Medicine in the UK.